Related Experiment Video
Updated: May 31, 2026
11:26
High-throughput Gene Tagging in Trypanosoma brucei
Published on: August 12, 2016
Producing parasitic helminth reference and draft genomes at the Wellcome Trust Sanger Institute
1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. neh@sanger.ac.uk
Parasite Immunology
|June 29, 2011
Summary
The Wellcome Trust Sanger Institute is sequencing parasitic helminth genomes using advanced technologies. This research aims to uncover genomic differences for developing novel vaccine therapies against these parasites.
Area of Science:
- Genomics
- Parasitology
- Molecular Biology
Background:
- Parasitic helminths pose significant global health challenges.
- Understanding helminth biology is crucial for developing effective treatments.
- Reference-quality genomes are essential for comparative genomics.
Purpose of the Study:
- To generate de novo reference-quality genomes for key parasitic helminth species.
- To enable comparative genomic analyses across different helminth species and strains.
- To identify novel genomic targets for vaccine therapies.
Main Methods:
- Utilizing second-generation sequencing technologies (Illumina and 454).
- Producing de novo reference genomes for cestodes, trematodes, and nematodes.
- Generating draft genome coverage for related strains and species.
Main Results:
- Established a comprehensive initiative for parasitic helminth genome sequencing.
- Enabled the comparison of species- and strain-specific genomic variations.
- Laid the groundwork for understanding the genetic basis of helminth biology.
Conclusions:
- Second-generation sequencing is revolutionizing parasite genomics.
- The generated reference genomes will accelerate the discovery of new therapeutic targets.
- This initiative is vital for advancing vaccine development against helminth infections.
